UB Paderborn / Katalog / Suche / in CDI

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014-04, Vol.17 (2), p.341-347

2014

Link zum Volltext

Verfügbarkeit prüfen

Nouvelles AMMs : pemigatinib dans les cholangiocarcinomes avec fusion ou réarrangement de FGFR2

Bulletin du cancer, 2021-05, Vol.108 (5), p.446-447

2021

Link zum Volltext

Verfügbarkeit prüfen

VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors

The Journal of experimental medicine, 2015-02, Vol.212 (2), p.139-148

2015

Link zum Volltext

Verfügbarkeit prüfen

VEGFA-VEGFR Pathway Blockade Inhibits Tumor-induced Regulatory T-cell Proliferation in Colorectal Cancer

Cancer research (Chicago, Ill.), 2013-01, Vol.73 (2), p.539-549

2013

Link zum Volltext

Verfügbarkeit prüfen

Human Epidermal Growth Factor Receptor 2 (HER2) in Advanced Gastric Cancer: Current Knowledge and Future Perspectives

Drugs (New York, N.Y.), 2020-03, Vol.80 (4), p.401-415

2020

Link zum Volltext

Verfügbarkeit prüfen

Adénocarcinome œsogastrique – nouvelles cibles thérapeutiques

Bulletin du cancer, 2023-05, Vol.110 (5), p.560-569

2023

Link zum Volltext

Verfügbarkeit prüfen

Checkpoint inhibitors and gastrointestinal immune-related adverse events

Current opinion in oncology, 2016-07, Vol.28 (4), p.264-268

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeting EZH2 to overcome the resistance to immunotherapy in microsatellite stable colorectal cancer: Results from the CAIRE study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3599-3599

2023

Link zum Volltext

Verfügbarkeit prüfen

Oesogastric cancer - new therapeutic targets

Bulletin du cancer, 2023-05, Vol.110 (5), p.560

2023

Link zum Volltext

Verfügbarkeit prüfen

Stratégie thérapeutique séquentielle : promesses et difficultés

Bulletin du cancer, 2021-05, Vol.108 (5), p.443-445

2021

Link zum Volltext

Verfügbarkeit prüfen

Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial

Clinical cancer research, 2021-04, Vol.27 (8), p.2139-2147

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of two nutritional scores' association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre study

European journal of cancer (1990), 2019-09, Vol.119, p.35-43

2019

Link zum Volltext

Verfügbarkeit prüfen

First in class TLR7/8 agonist BDB001 combined with atezolizumab and stereotactic body radiation therapy in patients with advanced pancreatic adenocarcinoma: Results from the AGADIR study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4153-4153

2023

Link zum Volltext

Verfügbarkeit prüfen

Reprogramming immune cells activity by furin-like enzymes as emerging strategy for enhanced immunotherapy in cancer

British journal of cancer, 2023-03, Vol.128 (7), p.1189-1195

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 126

Suche als RSS-Feed

Aktive Filter

ThemaColorectal Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(105)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(70)
Humans
(62)
Life Sciences & Biomedicine
(62)
Oncology
(32)
Life Sciences
(22)
Middle Aged
(20)
Cancer
(19)
Female
(19)
Male
(19)
Aged
(16)
Adult
(15)
Metastases
(14)
Chemotherapy
(13)
Gastroenterology & Hepatology
(13)
Metastasis
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Technology
(11)
Retrospective Studies
(10)
Engineering
(9)
Patients
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge

Control of the immune response by pro-angiogenic factors

The Give-and-Take Interaction Between the Tumor Microenvironment and Immune Cells Regulating Tumor Progression and Repression

Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort

Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study

REGOMUNE: A phase II study of regorafenib plus avelumab in solid tumors—Results of the non-MSI-H metastatic colorectal cancer (mCRC) cohort

Sulconazole inhibits PD-1 expression in immune cells and cancer cells malignant phenotype through NF-κB and calcium activity repression

Episomal HPV16 responsible for aggressive and deadly metastatic anal squamous cell carcinoma evidenced in peripheral blood

Furin Prodomain ppFurin Enhances Ca2+ Entry Through Orai and TRPC6 Channels’ Activation in Breast Cancer Cells

Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort

Nouvelles AMMs : pemigatinib dans les cholangiocarcinomes avec fusion ou réarrangement de FGFR2

VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors

VEGFA-VEGFR Pathway Blockade Inhibits Tumor-induced Regulatory T-cell Proliferation in Colorectal Cancer

Human Epidermal Growth Factor Receptor 2 (HER2) in Advanced Gastric Cancer: Current Knowledge and Future Perspectives

Adénocarcinome œsogastrique – nouvelles cibles thérapeutiques

Checkpoint inhibitors and gastrointestinal immune-related adverse events

Targeting EZH2 to overcome the resistance to immunotherapy in microsatellite stable colorectal cancer: Results from the CAIRE study

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial

Oesogastric cancer - new therapeutic targets

Stratégie thérapeutique séquentielle : promesses et difficultés

Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial

Evaluation of two nutritional scores' association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre study

First in class TLR7/8 agonist BDB001 combined with atezolizumab and stereotactic body radiation therapy in patients with advanced pancreatic adenocarcinoma: Results from the AGADIR study

Reprogramming immune cells activity by furin-like enzymes as emerging strategy for enhanced immunotherapy in cancer

Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study

Aktive Filter

Suchergebnisse filtern